Hematologic Malignancy
Tumors Derived from Langerhans Cells
CI-CAN-00001621Explore in graph →
HematologicNon-malignant12 active trials2 evidence items
- NCIt
- C150692
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001621Explore in graph →
Clinical trials
27 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002947 | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | terminated | Phase 1 | 35 | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Jul 2, 2014source: clinicaltrials